United Therapeutics Corporation Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale
United Therapeutics Corporation (UTHR) reported Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale of $0 for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-10-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale · last filed 2024-10-30
- United Therapeutics Corporation other-than-temporary impairment loss, debt securities, available-for-sale for the quarter ending 2024-09-30 was $0.00.
- United Therapeutics Corporation other-than-temporary impairment loss, debt securities, available-for-sale for the quarter ending 2024-06-30 was $0.00.
- United Therapeutics Corporation other-than-temporary impairment loss, debt securities, available-for-sale for the quarter ending 2024-03-31 was $0.00.
- United Therapeutics Corporation other-than-temporary impairment loss, debt securities, available-for-sale for the quarter ending 2023-12-31 was $0.00.
- United Therapeutics Corporation other-than-temporary impairment loss, debt securities, available-for-sale for fiscal 2023 was $0.00.
- United Therapeutics Corporation other-than-temporary impairment loss, debt securities, available-for-sale for fiscal 2022 was $0.00.
- United Therapeutics Corporation other-than-temporary impairment loss, debt securities, available-for-sale for fiscal 2021 was $0.00.
| Period end | Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale 3 month | Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale 6 month | Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale 9 month | Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale 12 month |
|---|---|---|---|---|
| 2024-09-30 | $0.00 10-Q · filed 2024-10-30 | $0.00 derived: sum of 2 quarters · filed 2024-10-30 | $0.00 10-Q · filed 2024-10-30 | $0.00 derived: sum of 4 quarters · filed 2024-10-30 |
| 2024-06-30 | $0.00 10-Q · filed 2024-07-31 | $0.00 10-Q · filed 2024-07-31 | $0.00 derived: sum of 3 quarters · filed 2024-07-31 | $0.00 derived: sum of 4 quarters · filed 2024-10-30 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-01 | $0.00 derived: sum of 2 quarters · filed 2024-05-01 | $0.00 derived: sum of 3 quarters · filed 2024-10-30 | $0.00 derived: sum of 4 quarters · filed 2024-10-30 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $0.00 derived: sum of 2 quarters · filed 2024-10-30 | $0.00 derived: sum of 3 quarters · filed 2024-10-30 | $0.00 10-K · filed 2024-02-21 |
| 2023-09-30 | $0.00 10-Q · filed 2024-10-30 | $0.00 derived: sum of 2 quarters · filed 2024-10-30 | $0.00 10-Q · filed 2024-10-30 | $0.00 derived: sum of 4 quarters · filed 2024-10-30 |
| 2023-06-30 | $0.00 10-Q · filed 2024-07-31 | $0.00 10-Q · filed 2024-07-31 | $0.00 derived: sum of 3 quarters · filed 2024-07-31 | $0.00 derived: sum of 4 quarters · filed 2024-07-31 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-01 | $0.00 derived: sum of 2 quarters · filed 2024-05-01 | $0.00 derived: sum of 3 quarters · filed 2024-05-01 | $0.00 derived: sum of 4 quarters · filed 2024-05-01 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $0.00 derived: sum of 2 quarters · filed 2024-02-21 | $0.00 derived: sum of 3 quarters · filed 2024-02-21 | $0.00 10-K · filed 2024-02-21 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-01 | $0.00 derived: sum of 2 quarters · filed 2023-11-01 | $0.00 10-Q · filed 2023-11-01 | $0.00 derived: sum of 4 quarters · filed 2023-11-01 |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-02 | $0.00 10-Q · filed 2023-08-02 | $0.00 derived: sum of 3 quarters · filed 2023-08-02 | $0.00 derived: sum of 4 quarters · filed 2023-08-02 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-03 | $0.00 derived: sum of 2 quarters · filed 2023-05-03 | $0.00 derived: sum of 3 quarters · filed 2023-05-03 | $0.00 derived: sum of 4 quarters · filed 2023-05-03 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $0.00 derived: sum of 2 quarters · filed 2023-02-22 | $0.00 derived: sum of 3 quarters · filed 2023-02-22 | $0.00 10-K · filed 2023-02-22 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-02 | $0.00 derived: sum of 2 quarters · filed 2022-11-02 | $0.00 10-Q · filed 2022-11-02 | |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-03 | $0.00 10-Q · filed 2022-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |